| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Peter Simmonds | Q28379677 |
| William G Powderly | Q61989166 | ||
| P2093 | author name string | Mario von Depka | |
| Michael Diamond | |||
| Christopher A Ludlam | |||
| Roshni Kulkarni | |||
| Bruce Ritchie | |||
| Michael L Tapper | |||
| Marion A Koerper | |||
| Samuel Bozzette | |||
| Jamie Siegel | |||
| Samuel Stanley | |||
| P2860 | cites work | Comparison of Flavivirus Universal Primer Pairs and Development of a Rapid, Highly Sensitive Heminested Reverse Transcription-PCR Assay for Detection of Flaviviruses Targeted to a Conserved Region of the NS5 Gene Sequences | Q24289061 |
| West Nile encephalitis | Q27469711 | ||
| Japanese viral encephalitis | Q27477893 | ||
| Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients | Q28274666 | ||
| Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons | Q28274676 | ||
| Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China | Q29618055 | ||
| Nipah virus: a recently emergent deadly paramyxovirus | Q30596767 | ||
| Hendra virus disease in horses | Q30630241 | ||
| TTV, a new human virus with single stranded circular DNA genome | Q30690640 | ||
| Social and environmental risk factors in the emergence of infectious diseases | Q30977705 | ||
| Neurovirulence and host factors in flavivirus encephalitis--evidence from clinical epidemiology | Q31055928 | ||
| Tissue archives to track blood borne pathogens in people receiving blood products | Q33194148 | ||
| Venezuelan haemorrhagic fever | Q33371803 | ||
| Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium-intracellulare infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings | Q33476923 | ||
| Host range relationships and the evolution of canine parvovirus | Q33748835 | ||
| Host range and interference studies of three classes of pig endogenous retrovirus | Q33786110 | ||
| Texas lifestyle limits transmission of dengue virus | Q33865496 | ||
| Neurologic complications in children with enterovirus 71 infection | Q33875092 | ||
| Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo | Q33935661 | ||
| Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. | Q33962399 | ||
| History of plasma-product safety | Q34300857 | ||
| Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders | Q45858187 | ||
| The need for recombinant factor VIII: historical background and rationale | Q45881498 | ||
| Factors predictive of death among HIV-uninfected persons with haemophilia and other congenital coagulation disorders | Q45888823 | ||
| Canine parvovirus myocarditis: clinical signs and pathological lesions encountered in natural cases | Q46696977 | ||
| Current and emerging infectious risks of blood transfusions | Q46883397 | ||
| Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. | Q51037857 | ||
| Molecular characterization of canine parvovirus in Brazil by polymerase chain reaction assay. | Q53878021 | ||
| Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy | Q57093007 | ||
| Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada | Q72347516 | ||
| Progressive multifocal leukoencephalopathy | Q73551630 | ||
| A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins | Q73794159 | ||
| Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre | Q74016225 | ||
| Immunoassay of human plasma cellular prion protein | Q77296717 | ||
| Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia | Q34301709 | ||
| The impact of HIV on mortality rates in the complete UK haemophilia population | Q34314355 | ||
| Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient | Q34339769 | ||
| Dengue and other emerging flaviviruses | Q34352435 | ||
| A new variant of Creutzfeldt-Jakob disease in the UK. | Q34374893 | ||
| BK virus in solid organ transplant recipients: an emerging syndrome | Q34451180 | ||
| TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity | Q34470729 | ||
| Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. | Q34705713 | ||
| Brain Tumors and Polyomaviruses | Q35112007 | ||
| Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy. | Q35112030 | ||
| West Nile virus in the United States: an update on an emerging infectious disease. | Q35210506 | ||
| Risks of transfusion-transmitted infections: 2003. | Q35561964 | ||
| West Nile virus: epidemiology and ecology in North America | Q35625021 | ||
| Emerging infectious threats to the blood supply | Q35640241 | ||
| Management of chronic hepatitis B in the HIV-infected patient. | Q35739563 | ||
| Dengue: an arthropod-borne disease of global importance | Q35775955 | ||
| HIV and hepatitis C virus co-infection | Q35818512 | ||
| Flavivirus encephalitis. | Q35842969 | ||
| Recombinant human enterovirus 71 in hand, foot and mouth disease patients. | Q35873152 | ||
| Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products | Q36349781 | ||
| Direct determination of the point mutation rate of a murine retrovirus | Q36698163 | ||
| Frequency, viral loads, and serotype identification of enterovirus infections in Scottish blood donors. | Q38464819 | ||
| An epizootic of Rift Valley fever in Egypt in 1977 | Q39240182 | ||
| Genetic characterization of type 2 porcine circovirus (PCV-2) from pigs with postweaning multisystemic wasting syndrome in different geographic regions of North America and development of a differential PCR-restriction fragment length polymorphism a | Q39459048 | ||
| Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. | Q40542265 | ||
| Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City | Q40572754 | ||
| Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan. | Q40585424 | ||
| Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents | Q40595199 | ||
| Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. | Q40628631 | ||
| Antigenic and genomic variabilities among recently prevalent parvoviruses of canine and feline origin in Japan | Q41512318 | ||
| Feline host range of canine parvovirus: recent emergence of new antigenic types in cats. | Q42269182 | ||
| The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports an African origin for the human T-lymphotropic/simian T-lymphotropic group of viruses | Q42628620 | ||
| Emerging infectious pathogens of wildlife. | Q42728385 | ||
| Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? | Q43036585 | ||
| Zoonosis in xenotransplantation | Q43214182 | ||
| Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation | Q43491687 | ||
| Ten years of clinical experiences with canine parvovirus infection CPV-2 infection) | Q44084821 | ||
| Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults | Q44289414 | ||
| Outbreak of severe neurologic involvement associated with Enterovirus 71 infection | Q44881432 | ||
| Fatal fruit bat virus sparks epidemics in southern Asia | Q45642854 | ||
| Emerging infectious diseases. Nipah virus (or a cousin) strikes again | Q45674247 | ||
| Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage | Q45838725 | ||
| P433 | issue | 9506 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | blood coagulation factors | Q49851203 |
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 252-261 | |
| P577 | publication date | 2006-01-01 | |
| 2006-01-21 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Clinical perspectives of emerging pathogens in bleeding disorders | |
| P478 | volume | 367 |
| Q55485778 | Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany. |
| Q36488803 | Blood safety and the choice of anti-hemophilic factor concentrate |
| Q36019034 | Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors |
| Q42256024 | Coagulation Factor IX for Hemophilia B Therapy |
| Q34659834 | Coagulation factor concentrates: past, present, and future. |
| Q35069871 | Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B. |
| Q38588576 | Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders |
| Q37841547 | Current options and new developments in the treatment of haemophilia |
| Q59357847 | Development of a serodiagnostic IgM-ELISA for tick-borne encephalitis virus using subviral particles with strep-tag |
| Q40758378 | Development of a serodiagnostic multi-species ELISA against tick-borne encephalitis virus using subviral particles |
| Q36715734 | Diagnostic approach to inherited bleeding disorders |
| Q37234113 | Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells |
| Q37625927 | Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/Bayer |
| Q43146818 | Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter? |
| Q38207134 | Innovative approach for improved rFVIII concentrate |
| Q38623914 | Malaria and blood transfusion: major issues of blood safety in malaria-endemic countries and strategies for mitigating the risk of Plasmodium parasites |
| Q44122887 | Managing haemophilia for life: 4th Haemophilia Global Summit. |
| Q42958772 | Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice |
| Q37266604 | Pathogen safety of plasma-derived products - Haemate P/Humate-P. |
| Q45869919 | Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance? |
| Q51135382 | Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications. |
| Q34416394 | Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy |
| Q38115586 | Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate |
| Q57173739 | The current and future role of plasma-derived clotting factor concentrate in the treatment of haemophilia A |
| Q30249200 | The safety of pharmacologic options for the treatment of persons with hemophilia |
| Q22305635 | Threat of dengue to blood safety in dengue-endemic countries |
Search more.